Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. - Wikidata - awgldk - TriplyDB

Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

http://www.wikidata.org/entity/Q37042111

about

Early detection of diabetic kidney disease: Present limitations and future perspectives Biomarkers of Renal Disease and Progression in Patients with Diabetes Clinical therapeutic strategies for early stage of diabetic kidney disease.Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria.Turmeric: Reemerging of a neglected Asian traditional remedy.A story of microalbuminuria and diabetic nephropathy Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS.Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.Association of race/ethnicity, inflammation, and albuminuria in patients with diabetes and early chronic kidney disease Inflammation in diabetic kidney disease Proteomic discovery of diabetic nephropathy biomarkers.Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study.TNF-α and microalbuminuria in patients with type 2 diabetes mellitus.Pirfenidone for diabetic nephropathy.Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.Circulating Tumor Necrosis Factor α Receptors Predict the Outcomes of Human IgA Nephropathy: A Prospective Cohort Study.Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes Gene Co-Expression Network Analysis for Identifying Modules and Functionally Enriched Pathways in Type 1 Diabetes.Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes.Soluble Tumor Necrosis Factor Receptor 1 Is Associated with Glomerular Filtration Rate Progression and Incidence of Chronic Kidney Disease in Two Community-Based Cohorts of Elderly Individuals.Diabetic nephropathy: What does the future hold?Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes.Postexercise phosphocreatine recovery, an index of mitochondrial oxidative phosphorylation, is reduced in diabetic patients with lower extremity complications Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.Systemic and renal lipids in kidney disease development and progression.Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.Early nephropathy in type 1 diabetes: the importance of early renal function decline.Plasma apolipoprotein L1 levels do not correlate with CKD.Tumor necrosis factor receptors: biology and therapeutic potential in kidney diseases.Novel biomarkers for the progression of diabetic nephropathy: soluble TNF receptors.Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment.Biomarkers in diabetic nephropathy: Present and future.Body fluid peptide and protein signatures in diabetic kidney diseases.The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease.

P2860

Q26741494-32CE14D8-3FB6-4CF6-90C5-8A4B639AD815 Q26799505-42445CB0-46E9-428C-84F6-329FB028D5EE Q30363683-B9C2F40B-1128-4007-A841-1811A0EFAE92 Q30371076-EF7DD4C2-29FD-4939-AC5C-F52AB1FE8463 Q30486649-C87A5DB0-B56F-46F0-8125-09572BF16A40 Q30486667-897AFA4C-C50A-420A-9E33-B634B572723B Q33421669-39EBB29A-9FD4-4A3F-91A3-DD6A4676EBFB Q33772238-41156802-360C-41E4-B780-AE05EA37EC81 Q33801646-26C97521-0D6A-4F5E-9985-E8689D94BAE2 Q34023543-283527B2-9D46-455C-9E68-3641012EBF52 Q34330236-8E32F319-0ED1-40EE-A7A1-080B7D1456D4 Q34336370-77AE097A-5FF0-496D-AE3A-8A47EF040DC6 Q34476839-B3B65A50-97F9-4CF2-BFAB-36DB9F089581 Q34629660-36627799-8D0B-4B6C-A92E-AD6DFC908421 Q34838338-7FB4BA13-FD5F-48F9-941F-3E0C861A6F0F Q35012444-E0011DF5-2AB8-4739-AAA4-445305012AAF Q35243559-2F2FE0EC-ABCB-4269-9EEC-E8CAD3979139 Q35364638-37219A71-3576-4AFF-B9B7-1C571E0845DF Q35630730-1C03F625-3337-4D83-8070-76159979D372 Q35692544-41158CEA-A216-49A1-9680-DC9250619999 Q35804154-FB1F2527-50D0-4120-98D1-60BA7214ED1B Q35804201-1488C8B1-8AB4-44A1-B062-6708455C4E51 Q36039529-BCC59A42-5D46-4120-8B78-6FF7F22B8FAE Q36200281-BE018311-4824-400D-A522-7080E68581E6 Q36325841-4A92B26D-F554-4134-B6DF-643A2CC36A12 Q36441616-D53A1F4D-3D9A-4D67-BC88-5403D059E253 Q36629282-7553182B-45A4-4149-8D0F-6C2A0BD36621 Q36723318-F2F013A1-82C6-4594-81B6-BBA73679530E Q36728193-46A0E859-3FCC-4FC2-8812-5C70B8239F3A Q36844894-1DCB8D70-F10F-4915-8568-12A925E591CF Q37148885-F100B244-C070-4FD4-9D2A-0738C11891D3 Q37403180-59134C62-BE5C-49C3-83F5-F0F5655C69E8 Q37418807-0D5B3015-4221-4F41-A4D9-FD4415244263 Q37604753-BE9616E7-83F4-4D6C-8E3F-1A1CB5452AA2 Q38042322-9F538B36-4F2F-42D5-AEDA-2063749821D3 Q38105277-F7A6F6EF-FE36-4B93-85EC-48BFEF8A91EB Q38255902-92D689A6-7C84-47DC-9399-D6428EA4131B Q38290083-590DCD34-B80B-4F40-8848-E0447E347045 Q38553924-D32EA052-3096-4035-84FC-DBE270D39369 Q38786133-60427316-2254-420B-9A9C-1264E890454E

P2860

Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

http://www.wikidata.org/entity/Q37042111

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum concentrations of marker ...... patients with type 1 diabetes.

@en

Serum concentrations of marker ...... patients with type 1 diabetes.

@nl

type

label

Serum concentrations of marker ...... patients with type 1 diabetes.

@en

Serum concentrations of marker ...... patients with type 1 diabetes.

@nl

prefLabel

Serum concentrations of marker ...... patients with type 1 diabetes.

@en

Serum concentrations of marker ...... patients with type 1 diabetes.

@nl

P1433

Q37042111-05FF9511-0A09-4269-9A92-4009B9B8BBDE

P1476

Q37042111-8804A8E9-182C-43B6-BF2D-97F1EA78E342

P2093

Q37042111-21F78458-A8B9-4EFD-8C51-A007CB252E00

Q37042111-434017A3-550C-4B7E-9BDF-F9CA36BECB65

Q37042111-639B3C9D-7A8B-4E10-9A1A-1A39D98E7615

Q37042111-6B3F3944-69D9-4F48-ABD4-AA1B237991DB

Q37042111-956EFDBC-3126-4EA3-8276-CD1B776D5F60

Q37042111-B2F6DFEA-D222-445A-979B-0EBE67347D8B

Q37042111-C0653E53-75D0-4FBE-965D-5050ABE8ABC6

P2860

Q37042111-00758BAD-1056-4843-8E2D-33B8CC81AA72

Q37042111-1AFCF6CF-0B7E-4680-B4E7-E23BAB487A81

Q37042111-3A1A1250-C7C1-47CF-8FD2-DCFDA379A4E0

Q37042111-4B3DB02C-911A-443E-874A-60C591FF3B88

Q37042111-4DE9D423-9F27-485C-AC14-96417CF6F65D

Q37042111-54024CE1-3EC1-417D-8D72-D449E2D6E831

Q37042111-5B7717D9-33A3-4E5D-A99B-FFC3B3684E4C

Q37042111-68994E8E-CE09-4F79-87E3-F8138369C28F

Q37042111-6CD52DBF-957A-4A3A-97EC-FA7AA76E8052

Q37042111-764A1F79-4541-46B8-8B73-C5C7B65D883A

P304

Q37042111-6069CC13-CD4D-4F7D-8B73-211155A4E686

P31

Q37042111-027960F1-CB89-4E21-BD83-3D9E4C0DB08B

P356

Q37042111-F7C2130F-6601-4666-A453-E5F76A21A9F0

P433

Q37042111-3025B523-3346-4840-B807-C6CFA78BD603

P478

Q37042111-544A605C-D6DC-414F-80AE-30720B6EAFE5

P50

Q37042111-BE8A2175-D42C-4426-8F93-F2B2FF65A0B5

P577

Q37042111-DA548390-B434-4C69-B4D8-0C28C4E10A50

P698

Q37042111-FE787532-0464-4125-A054-D4A0CE15050A

P921

Q37042111-15173088-CD5D-435D-BAA5-3E784B32036A

Q37042111-BD155386-177F-40C5-914B-0010C152AAF0

P932

Q37042111-02B99F29-B63D-4F1A-B3E5-C03CE50CE53C

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Serum concentrations of marker ...... patients with type 1 diabetes

@en

P2093

Amanda C Johnson

http://www.w3.org/2001/XMLSchema#string

Andrzej S Krolewski

http://www.w3.org/2001/XMLSchema#string

Bijan Roshan

http://www.w3.org/2001/XMLSchema#string

Elizabeth T Rosolowsky

http://www.w3.org/2001/XMLSchema#string

James H Warram

http://www.w3.org/2001/XMLSchema#string

Monika A Niewczas

http://www.w3.org/2001/XMLSchema#string

William Walker

http://www.w3.org/2001/XMLSchema#string

P2860

Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study

Leukocyte recruitment and vascular injury in diabetic nephropathy.

Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies.

Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures.

TNF receptor subtype signalling: differences and cellular consequences.

The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus.

The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications.

High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.

Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock.

Fas-dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure.

P304

62-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.03010608

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Linda H Ficociello

P577

2008-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19073786

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

2615709

http://www.w3.org/2001/XMLSchema#string